company background image
PHRR.F logo

PharmaTher Holdings OTCPK:PHRR.F Stock Report

Last Price

US$0.16

Market Cap

US$13.5m

7D

1.8%

1Y

-34.1%

Updated

30 Dec, 2024

Data

Company Financials

PharmaTher Holdings Ltd.

OTCPK:PHRR.F Stock Report

Market Cap: US$13.5m

PHRR.F Stock Overview

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. More details

PHRR.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (CA$0)

Earnings have declined by 40.8% per year over past 5 years

Does not have a meaningful market cap ($19M)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

PharmaTher Holdings Ltd. Competitors

ProPhase Labs

NasdaqCM:PRPH

US$15.2m

TherapeuticsMD

NasdaqGS:TXMD

US$12.6m

Jaguar Health

NasdaqCM:JAGX

US$12.2m

Cingulate

NasdaqCM:CING

US$15.4m

Price History & Performance

Summary of share price highs, lows and changes for PharmaTher Holdings
Historical stock prices
Current Share PriceCA$0.16
52 Week HighCA$0.32
52 Week LowCA$0.12
Beta3.37
1 Month Change-8.15%
3 Month Change-20.50%
1 Year Change-34.08%
3 Year Change-48.97%
5 Year Changen/a
Change since IPO-12.06%

Recent News & Updates

Recent updates

Shareholder Returns

PHRR.FUS PharmaceuticalsUS Market
7D1.8%1.3%0.6%
1Y-34.1%7.9%23.7%

Return vs Industry: PHRR.F underperformed the US Pharmaceuticals industry which returned 7.9% over the past year.

Return vs Market: PHRR.F underperformed the US Market which returned 23.7% over the past year.

Price Volatility

Is PHRR.F's price volatile compared to industry and market?
PHRR.F volatility
PHRR.F Average Weekly Movement13.5%
Pharmaceuticals Industry Average Movement10.5%
Market Average Movement6.3%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: PHRR.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PHRR.F's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2019n/aFabio Chianelliwww.pharmather.com

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.

PharmaTher Holdings Ltd. Fundamentals Summary

How do PharmaTher Holdings's earnings and revenue compare to its market cap?
PHRR.F fundamental statistics
Market capUS$13.53m
Earnings (TTM)-US$1.50m
Revenue (TTM)n/a

0.0x

P/S Ratio

-9.0x

P/E Ratio

Is PHRR.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHRR.F income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$2.16m
Earnings-CA$2.16m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.024
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PHRR.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 14:22
End of Day Share Price 2024/12/27 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PharmaTher Holdings Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick TrucchioH.C. Wainwright & Co.